Atom Investors »

Artiva Biotherapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $222k 23k 9.70

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Artiva Biotherapeutics

RA Capital Management
Viking Global Investors
Blackstone Group
5AM Venture Management
VR Adviser
Franklin Resources
Caligan Partners
Vanguard Capital Management
Samsara BioCapital
Blue Owl Capital Holdings
Propel Bio Management
BlackRock
Citadel Advisors
Silverarc Capital Management
Geode Capital Management

View all funds holding Artiva Biotherapeutics